Meeder Asset Management’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
|
|||||
|
2025
Q2 | $77.1K | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $1K | Buy |
|
|||||
|
2022
Q2 | $1K | Buy |
|
|||||
|
2022
Q1 | $1K | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $0 | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $135K | Sell |
|
|||||
|
2019
Q4 | $464K | Buy |
|
|||||
|
2019
Q3 | $18K | Sell |
|
|||||
|
2019
Q2 | $268K | Sell |
|
|||||
|
2019
Q1 | $237K | Buy |
|
|||||
|
2018
Q4 | $198K | Buy |
|
|||||
|
2018
Q3 | $6K | Buy |
|
|||||
|
2018
Q2 | $3.14K | Hold |
|
|||||
|
2018
Q1 | $3K | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $3K | Sell |
|
|||||
|
2017
Q1 | $13K | Sell |
|
|||||
|
2016
Q4 | $19K | Buy |
|
|||||
|
2015
Q4 | – | Sell |
|
|||||
|
2015
Q3 | $21K | Hold |
|
|||||
|
2015
Q2 | $35K | Hold |
|
|||||
|
2015
Q1 | $44K | Hold |
|
|||||
|
2014
Q4 | $44K | Hold |
|
|||||
|
2014
Q3 | $48K | Sell |
|
|||||
|
2014
Q2 | $64K | Hold |
|
|||||
|
2014
Q1 | $49K | Hold |
|
|||||
|
2013
Q4 | $40K | Hold |
|
|||||
|
2013
Q3 | $34K | Hold |
|
|||||
|
2013
Q2 | $20K | Buy |
|